Major facilitator superfamily MfsA contributes to multidrug resistance in emerging nosocomial pathogen Stenotrophomonas maltophilia. Dulyayangkul P, Charoenlap N, Srijaruskul K, Mongkolsuk S, Vattanaviboon P. J Antimicrob Chemother. 2016 Oct;71(10):2990-1. doi: 10.1093/jac/dkw233. No abstract

A structure-based virtual high-throughput screening, molecular docking, molecular dynamics and MM/PBSA study identified novel putative drug-like dual inhibitors of trypanosomal cruzain and rhodesain cysteine proteases Eurtivong C, Zimmer C, Schirmeister T, Butkinaree C, Saruengkhanphasit R, Niwetmarin W, Ruchirawat S, Bhambra AS Mol Drivers. 2024;28(2):531-51.

Targeted delivery of doxorubicin to A549 lung cancer cells by CXCR4 antagonist conjugated PLGA nanoparticles. Chittasupho C*,LirdprapamongkolK, Kewsuwan P, Sarisuta N. Eur J Pharm Biopharm. 2014 Oct;88(2):529-38.